“Investing in science. Building Impact."
Meneldor is a Dutch life-sciences investment firm backing exceptional science with value adding capital to build and scale European biopharma companies with real impact.
Our Team
Paul Lelieveld, Ir., MSc.
Founding Partner
Cees Stouten, MSc.
Senior Drug Development & Manufacturing Expert
Frans van Dalen, Pharm.D.
Founding Partner
Margrit Lelieveld-Solmsdorff
Strategy, Transformation & Leadership
Our Team
Paul Lelieveld, Ir., MSc.
Founding Partner
Frans van Dalen, Pharm.D.
Founding Partner
Margrit Lelieveld-Solmsdorff
Strategy, Transformation & Leadership
Cees Stouten, MSc.
Senior Drug Development & Manufacturing Expert
Portfolio
Meneldor invests in high-impact, science-driven innovations that address significant unmet medical needs and can be accelerated through smart translational strategies.
Important notice: Investments offered through this website are made under an exemption from the Dutch Financial Supervision Act (Wft).
As a result, these investments are not subject to supervision by the Dutch Authority for the Financial Markets (AFM).